All Content

CNST Article Slideshow

August 15, 2017

Here is a selection of articles that we would like to highlight on the site.

GW Pharmaceuticals Announces Results from Cancer Trial

February 13, 2017

On Feb. 7, 2017 GW Pharmaceuticals announced the results from a small Phase II study with tetrahydrocannabinol (THC) and cannabidiol (CBD) in 21 patients with recurrent glioblastoma multiforme (GBM).

AXIM Begins Clinical Trials with CBG Ointment

May 16, 2016

AXIM Biotechnologies, a Netherlands-based biotechnology company, announced that it would be entering clinical trials with its patent-pending cannabigerol (CBG) topical ointment formulation AX-1602, the company said in a May 16, 2016 press

Pages